Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantel Derma was a German medical technology company specializing in the development of high-quality laser systems for dermatology and aesthetic medicine. The company was well-known for its expertise in Erbium:YAG, CO2, and diode laser technologies, providing solutions for skin resurfacing, scar treatment, and vascular lesion removal. Originally operating as the dermatology arm of the French Quantel Group, it established a significant footprint in the European clinical market. In 2012, Quantel Derma was acquired by Alma Lasers, a move that integrated Quantel's precision German engineering with Alma's global distribution network. Following the acquisition, the company's operations were merged into Alma Lasers' portfolio, enhancing their offerings in the energy-based surgical and aesthetic segments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantel Derma.